Sequence requirements for the nuclear localization of the murine cytomegalovirus M44 gene product pp50

Citation
Lc. Loh et al., Sequence requirements for the nuclear localization of the murine cytomegalovirus M44 gene product pp50, VIROLOGY, 259(1), 1999, pp. 43-59
Citations number
37
Categorie Soggetti
Microbiology
Journal title
VIROLOGY
ISSN journal
00426822 → ACNP
Volume
259
Issue
1
Year of publication
1999
Pages
43 - 59
Database
ISI
SICI code
0042-6822(19990620)259:1<43:SRFTNL>2.0.ZU;2-O
Abstract
The murine cytomegalovirus (MCMV) M44 gene product pp50 is normally present in the nuclei of virus-infected cells. During transient expression of pp50 in COS-1 cells, the phosphoprotein was readily detectable in the nuclei, i ndicating that it possesses a nuclear localization signal (NLS). Studies on the subcellular locations of N- and C-terminal deletion mutants of pp50 su ggested that alterations in both the C terminus and the highly conserved N- terminal domains of pp50 affect nuclear localization. In particular, the C- terminal 11 amino acids of pp50, which includes a "KKQK" motif, were able t o mediate the import of a beta-galactosidase fusion protein into the nucleu s. The pair of lysine residues in this motif constitutes an essential eleme nt: of the C-terminal NLs as mutation of this motif to AAQK directly affect ed the nuclear localization of either pp50 or beta-galactosidase fusion pro teins containing the C-terminal portion of pp50. Furthermore our results in dicated that the functionality of the C-terminal NLS is dependent on the st ructural integrity of the highly conserved N-terminal portion of the molecu le, as deletion of amino acids 157-201 alone adversely affected nuclear loc alization. In the absence of a functional C-terminal NLS, the subcellular l ocalization of pp50 is sensitive to potential conformational changes induce d by mutations within the N-terminal half of the molecule. Under those circ umstances, mutation of the YK residues at position 22-23 or deletion of ami no acids 267-283 was sufficient to produce a protein that was impaired in n uclear import or retention. (C) 1999 Academic Press.